Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.

@article{Barkhof2007MagneticRI,
  title={Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.},
  author={Frederik Barkhof and Chris H. Polman and Ernst-Wilhelm Radue and Ludwig Kappos and M S Freedman and Gilles Edan and Hans-peter Hartung and David H. Miller and Xavier Montalban and Peter Poppe and Marlieke de Vos and Fatiha Lasri and Lars Bauer and Susanne Dahms and Klaus J. Wagner and Christoph Pohl and Rupert Sandbrink},
  journal={Archives of neurology},
  year={2007},
  volume={64 9},
  pages={
          1292-8
        }
}
BACKGROUND In the Betaseron/Betaferon in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT) study, interferon beta-1b delayed conversion to multiple sclerosis in patients with a first clinical event and at least 2 clinically silent brain magnetic resonance imaging (MRI) lesions. OBJECTIVE To examine detailed MRI findings from the first 2 years of this trial. DESIGN Double-blind, placebo-controlled, randomized, parallel-group, multicenter, phase 3 study. SETTING Ninety-eight… CONTINUE READING

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry

Kerstin Bendfeldt, Bernd Taschler, +21 authors Thomas E. Nichols
  • Brain Imaging and Behavior
  • 2018
VIEW 2 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

G Comi, M Filippi, F Barkhof
  • Lancet
  • 2001
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL